nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—ABCG2—Glyburide—gestational diabetes	0.211	0.513	CbGbCtD
Nilotinib—CYP2C9—Glyburide—gestational diabetes	0.0784	0.191	CbGbCtD
Nilotinib—ABCB1—Glyburide—gestational diabetes	0.0761	0.185	CbGbCtD
Nilotinib—CYP3A4—Glyburide—gestational diabetes	0.0456	0.111	CbGbCtD
Nilotinib—Myelosuppression—Glyburide—gestational diabetes	0.00824	0.0756	CcSEcCtD
Nilotinib—Drug eruption—Glyburide—gestational diabetes	0.00628	0.0577	CcSEcCtD
Nilotinib—CDC42BPB—islet of Langerhans—gestational diabetes	0.00622	0.0223	CbGeAlD
Nilotinib—MAPK8—islet of Langerhans—gestational diabetes	0.00563	0.0201	CbGeAlD
Nilotinib—MAPK8—embryo—gestational diabetes	0.00544	0.0195	CbGeAlD
Nilotinib—Cholestasis—Glyburide—gestational diabetes	0.00509	0.0467	CcSEcCtD
Nilotinib—EPHB3—embryo—gestational diabetes	0.00449	0.0161	CbGeAlD
Nilotinib—Hyperbilirubinaemia—Glyburide—gestational diabetes	0.00425	0.039	CcSEcCtD
Nilotinib—CDC42BPB—uterus—gestational diabetes	0.00406	0.0145	CbGeAlD
Nilotinib—MAPK11—adipose tissue—gestational diabetes	0.004	0.0143	CbGeAlD
Nilotinib—CDC42BPB—adipose tissue—gestational diabetes	0.00397	0.0142	CbGeAlD
Nilotinib—EPHA3—adipose tissue—gestational diabetes	0.00376	0.0135	CbGeAlD
Nilotinib—EPHA4—embryo—gestational diabetes	0.00375	0.0134	CbGeAlD
Nilotinib—MAPK8—uterus—gestational diabetes	0.00367	0.0131	CbGeAlD
Nilotinib—CA9—islet of Langerhans—gestational diabetes	0.00367	0.0131	CbGeAlD
Nilotinib—MAPK8—adipose tissue—gestational diabetes	0.00359	0.0128	CbGeAlD
Nilotinib—MAPK14—embryo—gestational diabetes	0.00346	0.0124	CbGeAlD
Nilotinib—EPHB2—head—gestational diabetes	0.00345	0.0123	CbGeAlD
Nilotinib—FGR—embryo—gestational diabetes	0.00344	0.0123	CbGeAlD
Nilotinib—EPHB4—islet of Langerhans—gestational diabetes	0.00339	0.0121	CbGeAlD
Nilotinib—EPHA2—islet of Langerhans—gestational diabetes	0.00332	0.0119	CbGeAlD
Nilotinib—EPHA8—head—gestational diabetes	0.0033	0.0118	CbGeAlD
Nilotinib—CDC42BPB—vagina—gestational diabetes	0.0033	0.0118	CbGeAlD
Nilotinib—MAP4K1—adipose tissue—gestational diabetes	0.00326	0.0117	CbGeAlD
Nilotinib—Hepatic function abnormal—Glyburide—gestational diabetes	0.00321	0.0295	CcSEcCtD
Nilotinib—TIE1—uterus—gestational diabetes	0.00318	0.0114	CbGeAlD
Nilotinib—Deafness—Glyburide—gestational diabetes	0.00314	0.0288	CcSEcCtD
Nilotinib—TEK—embryo—gestational diabetes	0.00314	0.0112	CbGeAlD
Nilotinib—TIE1—adipose tissue—gestational diabetes	0.00311	0.0111	CbGeAlD
Nilotinib—EPHB6—islet of Langerhans—gestational diabetes	0.0031	0.0111	CbGeAlD
Nilotinib—MAPK11—head—gestational diabetes	0.00307	0.011	CbGeAlD
Nilotinib—BRAF—uterus—gestational diabetes	0.00305	0.0109	CbGeAlD
Nilotinib—CDC42BPB—head—gestational diabetes	0.00305	0.0109	CbGeAlD
Nilotinib—EPHB3—uterus—gestational diabetes	0.00303	0.0108	CbGeAlD
Nilotinib—MAPK8—vagina—gestational diabetes	0.00298	0.0107	CbGeAlD
Nilotinib—BRAF—adipose tissue—gestational diabetes	0.00298	0.0107	CbGeAlD
Nilotinib—Dermatitis bullous—Glyburide—gestational diabetes	0.00293	0.0269	CcSEcCtD
Nilotinib—EPHA3—head—gestational diabetes	0.00289	0.0103	CbGeAlD
Nilotinib—Arthritis—Glyburide—gestational diabetes	0.00289	0.0265	CcSEcCtD
Nilotinib—Hypoglycaemia—Glyburide—gestational diabetes	0.00287	0.0264	CcSEcCtD
Nilotinib—PDGFRA—embryo—gestational diabetes	0.00284	0.0102	CbGeAlD
Nilotinib—Hyponatraemia—Glyburide—gestational diabetes	0.00282	0.0258	CcSEcCtD
Nilotinib—Diplopia—Glyburide—gestational diabetes	0.0028	0.0257	CcSEcCtD
Nilotinib—HCK—uterus—gestational diabetes	0.00278	0.00996	CbGeAlD
Nilotinib—MAPK8—head—gestational diabetes	0.00276	0.00987	CbGeAlD
Nilotinib—EPHA6—head—gestational diabetes	0.00276	0.00987	CbGeAlD
Nilotinib—HCK—adipose tissue—gestational diabetes	0.00272	0.00974	CbGeAlD
Nilotinib—MAP4K1—vagina—gestational diabetes	0.00271	0.00971	CbGeAlD
Nilotinib—ABL2—adipose tissue—gestational diabetes	0.0027	0.00968	CbGeAlD
Nilotinib—LYN—head—gestational diabetes	0.00254	0.00911	CbGeAlD
Nilotinib—EPHA4—uterus—gestational diabetes	0.00253	0.00905	CbGeAlD
Nilotinib—CSF1R—embryo—gestational diabetes	0.0025	0.00895	CbGeAlD
Nilotinib—CA3—uterus—gestational diabetes	0.0025	0.00894	CbGeAlD
Nilotinib—BRAF—vagina—gestational diabetes	0.00248	0.00888	CbGeAlD
Nilotinib—EPHA4—adipose tissue—gestational diabetes	0.00247	0.00885	CbGeAlD
Nilotinib—EPHB3—vagina—gestational diabetes	0.00246	0.00881	CbGeAlD
Nilotinib—CA3—adipose tissue—gestational diabetes	0.00244	0.00874	CbGeAlD
Nilotinib—Abdominal distension—Glyburide—gestational diabetes	0.00244	0.0224	CcSEcCtD
Nilotinib—Eosinophilia—Glyburide—gestational diabetes	0.0024	0.022	CcSEcCtD
Nilotinib—TIE1—head—gestational diabetes	0.00239	0.00855	CbGeAlD
Nilotinib—Pancreatitis—Glyburide—gestational diabetes	0.00238	0.0218	CcSEcCtD
Nilotinib—MAPK14—uterus—gestational diabetes	0.00233	0.00834	CbGeAlD
Nilotinib—LCK—uterus—gestational diabetes	0.00232	0.00831	CbGeAlD
Nilotinib—Pancytopenia—Glyburide—gestational diabetes	0.0023	0.0211	CcSEcCtD
Nilotinib—PDGFRB—islet of Langerhans—gestational diabetes	0.00229	0.00821	CbGeAlD
Nilotinib—MAPK14—adipose tissue—gestational diabetes	0.00228	0.00816	CbGeAlD
Nilotinib—EPHB3—head—gestational diabetes	0.00227	0.00814	CbGeAlD
Nilotinib—KIT—embryo—gestational diabetes	0.00227	0.00813	CbGeAlD
Nilotinib—LCK—adipose tissue—gestational diabetes	0.00227	0.00813	CbGeAlD
Nilotinib—FGR—adipose tissue—gestational diabetes	0.00227	0.00813	CbGeAlD
Nilotinib—HCK—vagina—gestational diabetes	0.00226	0.00809	CbGeAlD
Nilotinib—ABL2—vagina—gestational diabetes	0.00225	0.00804	CbGeAlD
Nilotinib—PDGFRB—embryo—gestational diabetes	0.00222	0.00794	CbGeAlD
Nilotinib—Photosensitivity reaction—Glyburide—gestational diabetes	0.00221	0.0203	CcSEcCtD
Nilotinib—EPHB4—uterus—gestational diabetes	0.00221	0.00791	CbGeAlD
Nilotinib—EPHB4—adipose tissue—gestational diabetes	0.00216	0.00774	CbGeAlD
Nilotinib—EPHA2—adipose tissue—gestational diabetes	0.00212	0.00759	CbGeAlD
Nilotinib—TEK—uterus—gestational diabetes	0.00211	0.00757	CbGeAlD
Nilotinib—Jaundice—Glyburide—gestational diabetes	0.00211	0.0193	CcSEcCtD
Nilotinib—HCK—head—gestational diabetes	0.00209	0.00748	CbGeAlD
Nilotinib—TEK—adipose tissue—gestational diabetes	0.00207	0.0074	CbGeAlD
Nilotinib—EPHA4—vagina—gestational diabetes	0.00205	0.00736	CbGeAlD
Nilotinib—ABL1—islet of Langerhans—gestational diabetes	0.00204	0.00732	CbGeAlD
Nilotinib—CA3—vagina—gestational diabetes	0.00203	0.00727	CbGeAlD
Nilotinib—CA6—head—gestational diabetes	0.00198	0.00709	CbGeAlD
Nilotinib—ABL1—embryo—gestational diabetes	0.00198	0.00708	CbGeAlD
Nilotinib—EPHB6—adipose tissue—gestational diabetes	0.00198	0.00708	CbGeAlD
Nilotinib—Hepatitis—Glyburide—gestational diabetes	0.00194	0.0178	CcSEcCtD
Nilotinib—PDGFRA—uterus—gestational diabetes	0.00192	0.00686	CbGeAlD
Nilotinib—EPHA4—head—gestational diabetes	0.0019	0.0068	CbGeAlD
Nilotinib—MAPK14—vagina—gestational diabetes	0.00189	0.00678	CbGeAlD
Nilotinib—FGR—vagina—gestational diabetes	0.00189	0.00676	CbGeAlD
Nilotinib—LCK—vagina—gestational diabetes	0.00189	0.00676	CbGeAlD
Nilotinib—CA3—head—gestational diabetes	0.00187	0.00671	CbGeAlD
Nilotinib—PDGFRA—adipose tissue—gestational diabetes	0.00187	0.00671	CbGeAlD
Nilotinib—Visual impairment—Glyburide—gestational diabetes	0.00187	0.0172	CcSEcCtD
Nilotinib—Eye disorder—Glyburide—gestational diabetes	0.00181	0.0166	CcSEcCtD
Nilotinib—EPHB4—vagina—gestational diabetes	0.0018	0.00643	CbGeAlD
Nilotinib—EPHA2—vagina—gestational diabetes	0.00176	0.00631	CbGeAlD
Nilotinib—MAPK14—head—gestational diabetes	0.00175	0.00627	CbGeAlD
Nilotinib—FGR—head—gestational diabetes	0.00174	0.00624	CbGeAlD
Nilotinib—Alopecia—Glyburide—gestational diabetes	0.00171	0.0157	CcSEcCtD
Nilotinib—MAP2K5—adipose tissue—gestational diabetes	0.00169	0.00605	CbGeAlD
Nilotinib—Malnutrition—Glyburide—gestational diabetes	0.00169	0.0155	CcSEcCtD
Nilotinib—Erythema—Glyburide—gestational diabetes	0.00169	0.0155	CcSEcCtD
Nilotinib—CSF1R—uterus—gestational diabetes	0.00169	0.00604	CbGeAlD
Nilotinib—CA4—islet of Langerhans—gestational diabetes	0.00168	0.00601	CbGeAlD
Nilotinib—CSF1R—adipose tissue—gestational diabetes	0.00165	0.0059	CbGeAlD
Nilotinib—EPHB6—vagina—gestational diabetes	0.00164	0.00588	CbGeAlD
Nilotinib—EPHA2—head—gestational diabetes	0.00163	0.00583	CbGeAlD
Nilotinib—Vision blurred—Glyburide—gestational diabetes	0.00159	0.0146	CcSEcCtD
Nilotinib—TEK—head—gestational diabetes	0.00159	0.00568	CbGeAlD
Nilotinib—Tremor—Glyburide—gestational diabetes	0.00158	0.0145	CcSEcCtD
Nilotinib—Anaemia—Glyburide—gestational diabetes	0.00156	0.0143	CcSEcCtD
Nilotinib—PDGFRA—vagina—gestational diabetes	0.00156	0.00558	CbGeAlD
Nilotinib—KIT—uterus—gestational diabetes	0.00153	0.00548	CbGeAlD
Nilotinib—EPHB6—head—gestational diabetes	0.00152	0.00543	CbGeAlD
Nilotinib—Leukopenia—Glyburide—gestational diabetes	0.00151	0.0139	CcSEcCtD
Nilotinib—KIT—adipose tissue—gestational diabetes	0.0015	0.00536	CbGeAlD
Nilotinib—PDGFRB—uterus—gestational diabetes	0.0015	0.00535	CbGeAlD
Nilotinib—PDGFRB—adipose tissue—gestational diabetes	0.00146	0.00524	CbGeAlD
Nilotinib—PDGFRA—head—gestational diabetes	0.00144	0.00515	CbGeAlD
Nilotinib—Myalgia—Glyburide—gestational diabetes	0.00144	0.0132	CcSEcCtD
Nilotinib—Arthralgia—Glyburide—gestational diabetes	0.00144	0.0132	CcSEcCtD
Nilotinib—MAP2K5—vagina—gestational diabetes	0.0014	0.00503	CbGeAlD
Nilotinib—CA2—islet of Langerhans—gestational diabetes	0.00139	0.00498	CbGeAlD
Nilotinib—Confusional state—Glyburide—gestational diabetes	0.00139	0.0128	CcSEcCtD
Nilotinib—Oedema—Glyburide—gestational diabetes	0.00138	0.0127	CcSEcCtD
Nilotinib—CSF1R—vagina—gestational diabetes	0.00137	0.00491	CbGeAlD
Nilotinib—CA1—adipose tissue—gestational diabetes	0.00137	0.0049	CbGeAlD
Nilotinib—Shock—Glyburide—gestational diabetes	0.00136	0.0124	CcSEcCtD
Nilotinib—Nervous system disorder—Glyburide—gestational diabetes	0.00135	0.0124	CcSEcCtD
Nilotinib—Thrombocytopenia—Glyburide—gestational diabetes	0.00135	0.0124	CcSEcCtD
Nilotinib—CA2—embryo—gestational diabetes	0.00135	0.00482	CbGeAlD
Nilotinib—ABL1—uterus—gestational diabetes	0.00133	0.00477	CbGeAlD
Nilotinib—Hyperhidrosis—Glyburide—gestational diabetes	0.00133	0.0122	CcSEcCtD
Nilotinib—CA12—head—gestational diabetes	0.00133	0.00475	CbGeAlD
Nilotinib—Anorexia—Glyburide—gestational diabetes	0.00131	0.0121	CcSEcCtD
Nilotinib—ABL1—adipose tissue—gestational diabetes	0.0013	0.00467	CbGeAlD
Nilotinib—MAP2K5—head—gestational diabetes	0.0013	0.00465	CbGeAlD
Nilotinib—Hypotension—Glyburide—gestational diabetes	0.00129	0.0118	CcSEcCtD
Nilotinib—CSF1R—head—gestational diabetes	0.00127	0.00453	CbGeAlD
Nilotinib—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.00126	0.0115	CcSEcCtD
Nilotinib—KIT—vagina—gestational diabetes	0.00124	0.00446	CbGeAlD
Nilotinib—Paraesthesia—Glyburide—gestational diabetes	0.00124	0.0114	CcSEcCtD
Nilotinib—Dyspnoea—Glyburide—gestational diabetes	0.00123	0.0113	CcSEcCtD
Nilotinib—PDGFRB—vagina—gestational diabetes	0.00122	0.00435	CbGeAlD
Nilotinib—Dyspepsia—Glyburide—gestational diabetes	0.00121	0.0111	CcSEcCtD
Nilotinib—Decreased appetite—Glyburide—gestational diabetes	0.0012	0.011	CcSEcCtD
Nilotinib—Gastrointestinal disorder—Glyburide—gestational diabetes	0.00119	0.0109	CcSEcCtD
Nilotinib—KIT—head—gestational diabetes	0.00115	0.00412	CbGeAlD
Nilotinib—Feeling abnormal—Glyburide—gestational diabetes	0.00114	0.0104	CcSEcCtD
Nilotinib—Gastrointestinal pain—Glyburide—gestational diabetes	0.00113	0.0103	CcSEcCtD
Nilotinib—PDGFRB—head—gestational diabetes	0.00112	0.00402	CbGeAlD
Nilotinib—Urticaria—Glyburide—gestational diabetes	0.0011	0.0101	CcSEcCtD
Nilotinib—Abdominal pain—Glyburide—gestational diabetes	0.00109	0.01	CcSEcCtD
Nilotinib—ABL1—vagina—gestational diabetes	0.00108	0.00388	CbGeAlD
Nilotinib—CA4—adipose tissue—gestational diabetes	0.00107	0.00383	CbGeAlD
Nilotinib—CA1—head—gestational diabetes	0.00105	0.00377	CbGeAlD
Nilotinib—Hypersensitivity—Glyburide—gestational diabetes	0.00102	0.00932	CcSEcCtD
Nilotinib—ABL1—head—gestational diabetes	0.001	0.00358	CbGeAlD
Nilotinib—Asthenia—Glyburide—gestational diabetes	0.000989	0.00908	CcSEcCtD
Nilotinib—Pruritus—Glyburide—gestational diabetes	0.000975	0.00895	CcSEcCtD
Nilotinib—Diarrhoea—Glyburide—gestational diabetes	0.000943	0.00866	CcSEcCtD
Nilotinib—CA2—adipose tissue—gestational diabetes	0.000888	0.00318	CbGeAlD
Nilotinib—Vomiting—Glyburide—gestational diabetes	0.000876	0.00805	CcSEcCtD
Nilotinib—Rash—Glyburide—gestational diabetes	0.000869	0.00798	CcSEcCtD
Nilotinib—Dermatitis—Glyburide—gestational diabetes	0.000868	0.00797	CcSEcCtD
Nilotinib—Headache—Glyburide—gestational diabetes	0.000864	0.00793	CcSEcCtD
Nilotinib—ABCG2—uterus—gestational diabetes	0.000841	0.00301	CbGeAlD
Nilotinib—ABCG2—adipose tissue—gestational diabetes	0.000822	0.00294	CbGeAlD
Nilotinib—CA4—head—gestational diabetes	0.000822	0.00294	CbGeAlD
Nilotinib—Nausea—Glyburide—gestational diabetes	0.000819	0.00752	CcSEcCtD
Nilotinib—CA2—vagina—gestational diabetes	0.000738	0.00264	CbGeAlD
Nilotinib—CYP2C8—vagina—gestational diabetes	0.000703	0.00252	CbGeAlD
Nilotinib—ABCG2—vagina—gestational diabetes	0.000683	0.00245	CbGeAlD
Nilotinib—CA2—head—gestational diabetes	0.000682	0.00244	CbGeAlD
Nilotinib—ABCB1—islet of Langerhans—gestational diabetes	0.000636	0.00228	CbGeAlD
Nilotinib—CYP2B6—vagina—gestational diabetes	0.00063	0.00226	CbGeAlD
Nilotinib—ABCB1—embryo—gestational diabetes	0.000615	0.0022	CbGeAlD
Nilotinib—CYP2B6—head—gestational diabetes	0.000582	0.00209	CbGeAlD
Nilotinib—CYP2D6—head—gestational diabetes	0.000433	0.00155	CbGeAlD
Nilotinib—ABCB1—uterus—gestational diabetes	0.000414	0.00148	CbGeAlD
Nilotinib—ABCB1—adipose tissue—gestational diabetes	0.000405	0.00145	CbGeAlD
Nilotinib—ABCB1—vagina—gestational diabetes	0.000337	0.00121	CbGeAlD
Nilotinib—ABCB1—head—gestational diabetes	0.000311	0.00111	CbGeAlD
Nilotinib—HCK—Disease—GCK—gestational diabetes	0.000195	0.000971	CbGpPWpGaD
Nilotinib—LCK—Signaling by SCF-KIT—FGF2—gestational diabetes	0.000194	0.000965	CbGpPWpGaD
Nilotinib—MAPK11—Regulation of toll-like receptor signaling pathway—TNF—gestational diabetes	0.000194	0.000964	CbGpPWpGaD
Nilotinib—EPHA2—Developmental Biology—FGF2—gestational diabetes	0.00019	0.000947	CbGpPWpGaD
Nilotinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000189	0.000941	CbGpPWpGaD
Nilotinib—MAPK8—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000188	0.000938	CbGpPWpGaD
Nilotinib—CA14—Metabolism—CYP19A1—gestational diabetes	0.000188	0.000935	CbGpPWpGaD
Nilotinib—CYP2C8—Biological oxidations—CYP19A1—gestational diabetes	0.000187	0.000932	CbGpPWpGaD
Nilotinib—PDGFRB—B Cell Activation—FGF2—gestational diabetes	0.000186	0.000928	CbGpPWpGaD
Nilotinib—LCK—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.000186	0.000924	CbGpPWpGaD
Nilotinib—ABL1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000185	0.00092	CbGpPWpGaD
Nilotinib—CYP2C8—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000185	0.000919	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—ADIPOQ—gestational diabetes	0.000184	0.000915	CbGpPWpGaD
Nilotinib—CA6—Metabolism—CYP19A1—gestational diabetes	0.000183	0.000911	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—ADIPOQ—gestational diabetes	0.000183	0.000911	CbGpPWpGaD
Nilotinib—LCK—Signaling by ERBB4—FGF2—gestational diabetes	0.000183	0.000909	CbGpPWpGaD
Nilotinib—LYN—B Cell Activation—FGF2—gestational diabetes	0.000183	0.000909	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—LEPR—gestational diabetes	0.00018	0.000898	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—MBL2—gestational diabetes	0.00018	0.000895	CbGpPWpGaD
Nilotinib—MAPK11—Signaling by NGF—FGF2—gestational diabetes	0.000178	0.000888	CbGpPWpGaD
Nilotinib—PDGFRB—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000178	0.000888	CbGpPWpGaD
Nilotinib—MAPK14—Toll-like Receptor Signaling Pathway—TNF—gestational diabetes	0.000177	0.000881	CbGpPWpGaD
Nilotinib—BRAF—Signaling by NGF—FGF2—gestational diabetes	0.000177	0.00088	CbGpPWpGaD
Nilotinib—MAPK14—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000176	0.000876	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—GGCT—gestational diabetes	0.000175	0.000869	CbGpPWpGaD
Nilotinib—LCK—Downstream signal transduction—FGF2—gestational diabetes	0.000174	0.000868	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—ADIPOQ—gestational diabetes	0.000174	0.000868	CbGpPWpGaD
Nilotinib—CA4—Metabolism—NAMPT—gestational diabetes	0.000174	0.000865	CbGpPWpGaD
Nilotinib—LCK—Signaling by FGFR—FGF2—gestational diabetes	0.000174	0.000864	CbGpPWpGaD
Nilotinib—CA4—Metabolism—GCK—gestational diabetes	0.000173	0.00086	CbGpPWpGaD
Nilotinib—LCK—Signaling by ERBB2—FGF2—gestational diabetes	0.000173	0.00086	CbGpPWpGaD
Nilotinib—LCK—DAP12 signaling—FGF2—gestational diabetes	0.000172	0.000855	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—LEPR—gestational diabetes	0.000171	0.000853	CbGpPWpGaD
Nilotinib—CA7—Metabolism—CYP19A1—gestational diabetes	0.000171	0.000851	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—MBL2—gestational diabetes	0.00017	0.000845	CbGpPWpGaD
Nilotinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000169	0.000843	CbGpPWpGaD
Nilotinib—EPHB3—Developmental Biology—TNF—gestational diabetes	0.000167	0.000832	CbGpPWpGaD
Nilotinib—CA2—Metabolism—NAMPT—gestational diabetes	0.000167	0.000829	CbGpPWpGaD
Nilotinib—MAPK14—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000166	0.000824	CbGpPWpGaD
Nilotinib—CA2—Metabolism—GCK—gestational diabetes	0.000166	0.000824	CbGpPWpGaD
Nilotinib—BRAF—MAPK Signaling Pathway—TNF—gestational diabetes	0.000165	0.00082	CbGpPWpGaD
Nilotinib—LCK—DAP12 interactions—FGF2—gestational diabetes	0.000162	0.000805	CbGpPWpGaD
Nilotinib—LCK—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000162	0.000805	CbGpPWpGaD
Nilotinib—LCK—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000162	0.000805	CbGpPWpGaD
Nilotinib—KIT—Signaling by NGF—FGF2—gestational diabetes	0.000161	0.000801	CbGpPWpGaD
Nilotinib—LCK—Signaling by EGFR—FGF2—gestational diabetes	0.00016	0.000798	CbGpPWpGaD
Nilotinib—CA1—Metabolism—NAMPT—gestational diabetes	0.00016	0.000795	CbGpPWpGaD
Nilotinib—LCK—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000159	0.000791	CbGpPWpGaD
Nilotinib—CA1—Metabolism—GCK—gestational diabetes	0.000159	0.00079	CbGpPWpGaD
Nilotinib—CA12—Metabolism—CYP19A1—gestational diabetes	0.000158	0.000788	CbGpPWpGaD
Nilotinib—LCK—Signaling by PDGF—FGF2—gestational diabetes	0.000158	0.000787	CbGpPWpGaD
Nilotinib—BRAF—Disease—RBP4—gestational diabetes	0.000157	0.000779	CbGpPWpGaD
Nilotinib—CYP2D6—Biological oxidations—CYP19A1—gestational diabetes	0.000154	0.000765	CbGpPWpGaD
Nilotinib—KIT—Immune System—MBL2—gestational diabetes	0.000153	0.000762	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—GLS2—gestational diabetes	0.000153	0.00076	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling by NGF—FGF2—gestational diabetes	0.000152	0.000758	CbGpPWpGaD
Nilotinib—CYP2C9—Biological oxidations—CYP19A1—gestational diabetes	0.000152	0.000758	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—LEP—gestational diabetes	0.000152	0.000755	CbGpPWpGaD
Nilotinib—CYP2D6—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000152	0.000754	CbGpPWpGaD
Nilotinib—ABCG2—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000151	0.00075	CbGpPWpGaD
Nilotinib—CYP2C9—Metapathway biotransformation—CYP19A1—gestational diabetes	0.00015	0.000748	CbGpPWpGaD
Nilotinib—LCK—B Cell Activation—FGF2—gestational diabetes	0.00015	0.000745	CbGpPWpGaD
Nilotinib—EPHA3—Developmental Biology—TNF—gestational diabetes	0.000149	0.000742	CbGpPWpGaD
Nilotinib—ABL2—Developmental Biology—TNF—gestational diabetes	0.000149	0.000742	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—GGCT—gestational diabetes	0.000148	0.000738	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000146	0.000726	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—MBL2—gestational diabetes	0.000145	0.000721	CbGpPWpGaD
Nilotinib—EPHA8—Developmental Biology—TNF—gestational diabetes	0.000144	0.000715	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—LEPR—gestational diabetes	0.000144	0.000715	CbGpPWpGaD
Nilotinib—LCK—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000143	0.000713	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—MTNR1B—gestational diabetes	0.000143	0.00071	CbGpPWpGaD
Nilotinib—KIT—Disease—RBP4—gestational diabetes	0.000143	0.000709	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—LEPR—gestational diabetes	0.000142	0.000709	CbGpPWpGaD
Nilotinib—EPHB4—Developmental Biology—TNF—gestational diabetes	0.000142	0.000707	CbGpPWpGaD
Nilotinib—EPHA4—Developmental Biology—TNF—gestational diabetes	0.000142	0.000707	CbGpPWpGaD
Nilotinib—HCK—Innate Immune System—FGF2—gestational diabetes	0.000141	0.000702	CbGpPWpGaD
Nilotinib—BRAF—Disease—NAMPT—gestational diabetes	0.00014	0.000699	CbGpPWpGaD
Nilotinib—CA9—Metabolism—NAMPT—gestational diabetes	0.00014	0.000699	CbGpPWpGaD
Nilotinib—BRAF—Disease—GCK—gestational diabetes	0.00014	0.000695	CbGpPWpGaD
Nilotinib—CA9—Metabolism—GCK—gestational diabetes	0.00014	0.000695	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—RBP4—gestational diabetes	0.000139	0.000691	CbGpPWpGaD
Nilotinib—MAPK14—Regulation of toll-like receptor signaling pathway—TNF—gestational diabetes	0.000138	0.000688	CbGpPWpGaD
Nilotinib—EPHB2—Developmental Biology—TNF—gestational diabetes	0.000138	0.000685	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by NGF—FGF2—gestational diabetes	0.000137	0.000683	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—MTNR1B—gestational diabetes	0.000136	0.000675	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—RBP4—gestational diabetes	0.000135	0.000672	CbGpPWpGaD
Nilotinib—EPHB6—Developmental Biology—TNF—gestational diabetes	0.000134	0.000665	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—RBP4—gestational diabetes	0.000132	0.000657	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—MBL2—gestational diabetes	0.000131	0.00065	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—LEPR—gestational diabetes	0.00013	0.000645	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—GLS2—gestational diabetes	0.00013	0.000645	CbGpPWpGaD
Nilotinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000128	0.000638	CbGpPWpGaD
Nilotinib—PDGFRB—MAPK Signaling Pathway—TNF—gestational diabetes	0.000128	0.000637	CbGpPWpGaD
Nilotinib—KIT—Disease—NAMPT—gestational diabetes	0.000128	0.000636	CbGpPWpGaD
Nilotinib—LYN—Immune System—MBL2—gestational diabetes	0.000128	0.000636	CbGpPWpGaD
Nilotinib—MAPK8—Innate Immune System—FGF2—gestational diabetes	0.000128	0.000636	CbGpPWpGaD
Nilotinib—MAPK14—Signaling by NGF—FGF2—gestational diabetes	0.000127	0.000634	CbGpPWpGaD
Nilotinib—FGR—Innate Immune System—FGF2—gestational diabetes	0.000127	0.000634	CbGpPWpGaD
Nilotinib—ABL1—Immune System—MBL2—gestational diabetes	0.000127	0.000633	CbGpPWpGaD
Nilotinib—KIT—Disease—GCK—gestational diabetes	0.000127	0.000632	CbGpPWpGaD
Nilotinib—CA4—Metabolism—CYP19A1—gestational diabetes	0.000126	0.000629	CbGpPWpGaD
Nilotinib—EPHA6—Developmental Biology—TNF—gestational diabetes	0.000126	0.000625	CbGpPWpGaD
Nilotinib—BLK—Adaptive Immune System—FGF2—gestational diabetes	0.000123	0.000611	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—LEPR—gestational diabetes	0.000123	0.00061	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—RBP4—gestational diabetes	0.000122	0.000605	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—MBL2—gestational diabetes	0.000121	0.000603	CbGpPWpGaD
Nilotinib—CA2—Metabolism—CYP19A1—gestational diabetes	0.000121	0.000603	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—NAMPT—gestational diabetes	0.000121	0.000602	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—GCK—gestational diabetes	0.00012	0.000599	CbGpPWpGaD
Nilotinib—MAPK14—MAPK Signaling Pathway—TNF—gestational diabetes	0.000119	0.000591	CbGpPWpGaD
Nilotinib—CA1—Metabolism—CYP19A1—gestational diabetes	0.000116	0.000578	CbGpPWpGaD
Nilotinib—EPHA2—Developmental Biology—TNF—gestational diabetes	0.000116	0.000577	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—FGF2—gestational diabetes	0.000115	0.000574	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—LEP—gestational diabetes	0.000114	0.000569	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—LEP—gestational diabetes	0.000114	0.000566	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—MTNR1B—gestational diabetes	0.000114	0.000565	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—MTNR1B—gestational diabetes	0.000113	0.00056	CbGpPWpGaD
Nilotinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000113	0.00056	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—RBP4—gestational diabetes	0.000111	0.000551	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—LEPR—gestational diabetes	0.00011	0.00055	CbGpPWpGaD
Nilotinib—LCK—Signaling by NGF—FGF2—gestational diabetes	0.00011	0.000548	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—RBP4—gestational diabetes	0.00011	0.000546	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—NAMPT—gestational diabetes	0.000109	0.000543	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—GGCT—gestational diabetes	0.000109	0.000541	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—GCK—gestational diabetes	0.000108	0.000539	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—LEP—gestational diabetes	0.000108	0.000539	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—LEPR—gestational diabetes	0.000108	0.000538	CbGpPWpGaD
Nilotinib—MAPK11—Gene Expression—AR—gestational diabetes	0.000108	0.000537	CbGpPWpGaD
Nilotinib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000107	0.000533	CbGpPWpGaD
Nilotinib—LCK—Immune System—MBL2—gestational diabetes	0.000105	0.000522	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—LEPR—gestational diabetes	0.000103	0.00051	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—MTNR1B—gestational diabetes	0.000102	0.00051	CbGpPWpGaD
Nilotinib—CA9—Metabolism—CYP19A1—gestational diabetes	0.000102	0.000508	CbGpPWpGaD
Nilotinib—MAPK11—Innate Immune System—FGF2—gestational diabetes	0.000102	0.000507	CbGpPWpGaD
Nilotinib—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	0.0001	0.0005	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—RBP4—gestational diabetes	9.98e-05	0.000497	CbGpPWpGaD
Nilotinib—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	9.91e-05	0.000493	CbGpPWpGaD
Nilotinib—ABCB1—Allograft Rejection—TNF—gestational diabetes	9.83e-05	0.000489	CbGpPWpGaD
Nilotinib—LCK—Disease—RBP4—gestational diabetes	9.75e-05	0.000486	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—MTNR1B—gestational diabetes	9.7e-05	0.000483	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—GLS2—gestational diabetes	9.5e-05	0.000473	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—RBP4—gestational diabetes	9.45e-05	0.00047	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GGCT—gestational diabetes	9.2e-05	0.000458	CbGpPWpGaD
Nilotinib—KIT—Innate Immune System—FGF2—gestational diabetes	9.18e-05	0.000457	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—LEPR—gestational diabetes	8.87e-05	0.000441	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—FGF2—gestational diabetes	8.81e-05	0.000439	CbGpPWpGaD
Nilotinib—LCK—Disease—NAMPT—gestational diabetes	8.75e-05	0.000435	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—MTNR1B—gestational diabetes	8.73e-05	0.000435	CbGpPWpGaD
Nilotinib—LCK—Disease—GCK—gestational diabetes	8.69e-05	0.000433	CbGpPWpGaD
Nilotinib—PDGFRA—Innate Immune System—FGF2—gestational diabetes	8.69e-05	0.000433	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—FGF2—gestational diabetes	8.68e-05	0.000432	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—FGF2—gestational diabetes	8.64e-05	0.00043	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—MTNR1B—gestational diabetes	8.55e-05	0.000426	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—RBP4—gestational diabetes	8.51e-05	0.000424	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—NAMPT—gestational diabetes	8.37e-05	0.000416	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—FGF2—gestational diabetes	8.34e-05	0.000415	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—RBP4—gestational diabetes	8.33e-05	0.000415	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—GCK—gestational diabetes	8.31e-05	0.000414	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—FGF2—gestational diabetes	8.23e-05	0.000409	CbGpPWpGaD
Nilotinib—HCK—Immune System—FGF2—gestational diabetes	8.21e-05	0.000409	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	8.14e-05	0.000405	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—MTNR1B—gestational diabetes	8.11e-05	0.000404	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GLS2—gestational diabetes	8.04e-05	0.0004	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GGCT—gestational diabetes	8.01e-05	0.000399	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	7.97e-05	0.000397	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—RBP4—gestational diabetes	7.9e-05	0.000393	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—FGF2—gestational diabetes	7.83e-05	0.00039	CbGpPWpGaD
Nilotinib—MAPK14—Gene Expression—AR—gestational diabetes	7.7e-05	0.000383	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—FGF2—gestational diabetes	7.66e-05	0.000381	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—FGF2—gestational diabetes	7.63e-05	0.00038	CbGpPWpGaD
Nilotinib—HCK—Disease—FGF2—gestational diabetes	7.58e-05	0.000377	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GGCT—gestational diabetes	7.55e-05	0.000376	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—FGF2—gestational diabetes	7.52e-05	0.000374	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GGCT—gestational diabetes	7.49e-05	0.000373	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—FGF2—gestational diabetes	7.44e-05	0.00037	CbGpPWpGaD
Nilotinib—BLK—Immune System—FGF2—gestational diabetes	7.44e-05	0.00037	CbGpPWpGaD
Nilotinib—FGR—Immune System—FGF2—gestational diabetes	7.42e-05	0.000369	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—FGF2—gestational diabetes	7.36e-05	0.000366	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—FGF2—gestational diabetes	7.27e-05	0.000362	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	7.19e-05	0.000358	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—NAMPT—gestational diabetes	7.1e-05	0.000353	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—GCK—gestational diabetes	7.05e-05	0.000351	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—TNF—gestational diabetes	7.02e-05	0.000349	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—MTNR1B—gestational diabetes	7.01e-05	0.000349	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GLS2—gestational diabetes	7e-05	0.000349	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—RBP4—gestational diabetes	6.83e-05	0.00034	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GLS2—gestational diabetes	6.6e-05	0.000329	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GLS2—gestational diabetes	6.54e-05	0.000326	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—LEP—gestational diabetes	6.33e-05	0.000315	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—FGF2—gestational diabetes	6.28e-05	0.000313	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—CYP19A1—gestational diabetes	6.08e-05	0.000303	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—FGF2—gestational diabetes	6.03e-05	0.0003	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—LEP—gestational diabetes	6.02e-05	0.0003	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—FGF2—gestational diabetes	5.93e-05	0.000295	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	5.85e-05	0.000291	CbGpPWpGaD
Nilotinib—BRAF—Disease—FGF2—gestational diabetes	5.42e-05	0.00027	CbGpPWpGaD
Nilotinib—KIT—Immune System—FGF2—gestational diabetes	5.35e-05	0.000266	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—TNF—gestational diabetes	5.28e-05	0.000263	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—TNF—gestational diabetes	5.26e-05	0.000262	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—NAMPT—gestational diabetes	5.2e-05	0.000259	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—GCK—gestational diabetes	5.17e-05	0.000257	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—CYP19A1—gestational diabetes	5.16e-05	0.000257	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—FGF2—gestational diabetes	5.06e-05	0.000252	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—LEP—gestational diabetes	5.05e-05	0.000251	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—TNF—gestational diabetes	5.01e-05	0.000249	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—LEP—gestational diabetes	5e-05	0.000249	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GGCT—gestational diabetes	4.94e-05	0.000246	CbGpPWpGaD
Nilotinib—KIT—Disease—FGF2—gestational diabetes	4.94e-05	0.000246	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	4.85e-05	0.000242	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—FGF2—gestational diabetes	4.81e-05	0.000239	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—FGF2—gestational diabetes	4.67e-05	0.000233	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—FGF2—gestational diabetes	4.57e-05	0.000228	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—FGF2—gestational diabetes	4.56e-05	0.000227	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—LEP—gestational diabetes	4.55e-05	0.000226	CbGpPWpGaD
Nilotinib—LYN—Immune System—FGF2—gestational diabetes	4.46e-05	0.000222	CbGpPWpGaD
Nilotinib—ABL1—Immune System—FGF2—gestational diabetes	4.44e-05	0.000221	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—NAMPT—gestational diabetes	4.41e-05	0.000219	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GCK—gestational diabetes	4.38e-05	0.000218	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GLS2—gestational diabetes	4.32e-05	0.000215	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—LEP—gestational diabetes	4.31e-05	0.000214	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—FGF2—gestational diabetes	4.23e-05	0.000211	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—FGF2—gestational diabetes	4.21e-05	0.00021	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—LEP—gestational diabetes	3.88e-05	0.000193	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—NAMPT—gestational diabetes	3.84e-05	0.000191	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—FGF2—gestational diabetes	3.83e-05	0.000191	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GCK—gestational diabetes	3.81e-05	0.00019	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—LEP—gestational diabetes	3.8e-05	0.000189	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—FGF2—gestational diabetes	3.8e-05	0.000189	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—CYP19A1—gestational diabetes	3.78e-05	0.000188	CbGpPWpGaD
Nilotinib—LCK—Immune System—FGF2—gestational diabetes	3.66e-05	0.000182	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—NAMPT—gestational diabetes	3.62e-05	0.00018	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—LEP—gestational diabetes	3.6e-05	0.000179	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GCK—gestational diabetes	3.59e-05	0.000179	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—NAMPT—gestational diabetes	3.59e-05	0.000178	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GCK—gestational diabetes	3.56e-05	0.000177	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—FGF2—gestational diabetes	3.46e-05	0.000172	CbGpPWpGaD
Nilotinib—LCK—Disease—FGF2—gestational diabetes	3.38e-05	0.000168	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—FGF2—gestational diabetes	3.27e-05	0.000163	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CYP19A1—gestational diabetes	3.2e-05	0.000159	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—LEP—gestational diabetes	3.11e-05	0.000155	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—FGF2—gestational diabetes	2.95e-05	0.000147	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—FGF2—gestational diabetes	2.89e-05	0.000144	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CYP19A1—gestational diabetes	2.79e-05	0.000139	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—FGF2—gestational diabetes	2.74e-05	0.000136	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CYP19A1—gestational diabetes	2.63e-05	0.000131	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CYP19A1—gestational diabetes	2.6e-05	0.00013	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—FGF2—gestational diabetes	2.37e-05	0.000118	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—NAMPT—gestational diabetes	2.36e-05	0.000118	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GCK—gestational diabetes	2.35e-05	0.000117	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CYP19A1—gestational diabetes	1.72e-05	8.55e-05	CbGpPWpGaD
